The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study

被引:20
作者
Campo, Gianluca [1 ,2 ]
Pavasini, Rita [1 ]
Maietti, Elisa [3 ]
Tonet, Elisabetta [1 ]
Cimaglia, Paolo [1 ]
Scillitani, Giulia [1 ]
Bugani, Giulia [1 ]
Serenelli, Matteo [1 ]
Zaraket, Fatima [1 ]
Balla, Cristina [1 ]
Trevisan, Filippo [1 ]
Biscaglia, Simone [1 ]
Sassone, Biagio [4 ]
Galvani, Marcello [5 ]
Ferrari, Roberto [1 ,2 ,6 ]
Volpato, Stefano [3 ]
机构
[1] Univ Ferrara, Azienda Osped, Cardiovasc Inst, Cardiol Unit, Via Aldo Moro 8, I-44124 Cona, FE, Italy
[2] LTTA Ctr, Ferrara, Italy
[3] Univ Ferrara, Dept Med Sci, Ferrara, Italy
[4] Cento Hosp, Div Cardiol, Ferrara, Italy
[5] Osped GB Morgagni, Unita Operat Cardiol, Forli, Italy
[6] ES Hlth Sci Fdn, GVM Care & Res, Maria Cecilia Hosp, Cotignola, Italy
关键词
Acute coronary syndrome; Frailty; Short physical performance battery; Handgrip; Multidimensional performance test; Clinical frailty score; PERCUTANEOUS CORONARY INTERVENTION; MULTIDIMENSIONAL PROGNOSTIC INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; ELEVATION MYOCARDIAL-INFARCTION; LOWER-EXTREMITY PERFORMANCE; 1-YEAR CLINICAL-OUTCOMES; PHYSICAL PERFORMANCE; OLDER-ADULTS; MORTALITY; STENT;
D O I
10.1007/s40520-016-0662-y
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Frailty has become a high-priority issue in cardiovascular medicine because of the aging of cardiovascular patients. Simple and reproducible tools to assess frailty in elderly patients are clearly on demand. Their application may help physicians in the selection of invasive and medical treatments and in the timing and modality of the follow-up. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program is designed with the aim to validate the use of the short physical performance battery (SPPB) as prognostic tools in patients admitted to hospital for acute coronary syndrome (ACS). Methods The FRASER program is a multicenter prospective study involving 4 Italian cardiology units. The FRASER program enrolls only patients aged >= 70 years. The core of the FRASER program includes patients admitted to hospital for ACS. The aims are (1) to describe SPPB distribution before hospital discharge and (2) to investigate the prognostic role of SPPB score. The primary outcome is a composite of 1-year all-cause mortality and hospital readmission for any cause. Ancillary analyses will be focused on different study populations (patients hospitalized for arrhythmias or acute heart failure or symptomatic severe aortic stenosis) and on different tools to assess frailty (multidimensional prognostic index, clinical frailty score, grip strength). Discussion The FRASER program will fill critical gaps in the knowledge regarding the link between frailty, cardiovascular disease, interventional procedures and outcome and will help physicians in the generation of a more personalized risk assessment and in the identification of potential targets for interventions.
引用
收藏
页码:895 / 903
页数:9
相关论文
共 42 条
  • [1] Cognitive function, gait speed decline, and comorbidities: The health, aging and body composition study
    Atkinson, Hal H.
    Rosano, Caterina
    Simonsick, Eleanor M.
    Williamson, Jeff D.
    Davis, Cralen
    Ambrosius, Walter T.
    Rapp, Stephen R.
    Cesari, Matteo
    Newman, Anne B.
    Harris, Tamara B.
    Rubin, Susan M.
    Yaffe, Kristine
    Satterfield, Suzanne
    Kritchevsky, Stephen B.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2007, 62 (08): : 844 - 850
  • [2] Frailty: An emerging research and clinical paradigm - Issues and controversies
    Bergman, Howard
    Ferrucci, Luigi
    Guralnik, Jack
    Hogan, David B.
    Hummel, Silvia
    Karunananthan, Sathya
    Wolfson, Christina
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2007, 62 (07): : 731 - 737
  • [3] Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry
    Biscaglia, Simone
    Campo, Gianluca
    Pavasini, Rita
    Tebaldi, Matteo
    Tumscitz, Carlo
    Ferrari, Roberto
    [J]. PLATELETS, 2016, 27 (05) : 484 - 487
  • [4] Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention
    Campo, G.
    Ferraresi, P.
    Marchesini, J.
    Bernardi, F.
    Valgimigli, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 2106 - 2108
  • [5] Tissue factor and coagulation factor VII levels during acute myocardial infarction - Association with genotype and adverse events
    Campo, Gianluca
    Valgimigli, Marco
    Ferraresi, Paolo
    Malagutti, Patrizia
    Baroni, Marcello
    Arcozzi, Chiara
    Gemmati, Donato
    Percoco, Gianfranco
    Parrinello, Giovanni
    Ferrari, Roberto
    Bernardi, Francesco
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) : 2800 - 2806
  • [6] Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings
    Campo, Gianluca
    Morciano, Giampaolo
    Pavasini, Rita
    Bonora, Massimo
    Sbano, Luigi
    Biscaglia, Simone
    Bovolenta, Matteo
    Pinotti, Mirko
    Punzetti, Silvia
    Rizzo, Paola
    Aquila, Giorgio
    Giorgi, Carlotta
    Ferrari, Roberto
    Pinton, Paolo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 993 - 997
  • [7] Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD
    Campo, Gianluca
    Pavasini, Rita
    Malagu, Michele
    Punzetti, Silvia
    Napoli, Nicola
    Guerzoni, Franco
    Papi, Alberto
    Ceconi, Claudio
    Contoli, Marco
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (05) : 560 - 567
  • [8] Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study
    Campo, Gianluca
    Pavasini, Rita
    Biscaglia, Simone
    Ferri, Alessandra
    Andrenacci, Elisa
    Tebaldi, Matteo
    Ferrari, Roberto
    [J]. PHARMACOLOGICAL RESEARCH, 2015, 97 : 1 - 6
  • [9] The in vitro effects of verbascoside on human platelet aggregation
    Campo, Gianluca
    Marchesini, Jlenia
    Bristot, Laura
    Monti, Monia
    Gambetti, Stefania
    Pavasini, Rita
    Pollina, Alberto
    Ferrari, Roberto
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 318 - 325
  • [10] Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention
    Campo, Gianluca
    Saia, Francesco
    Guastaroba, Paolo
    Marchesini, Jlenia
    Varani, Elisabetta
    Manari, Antonio
    Ottani, Filippo
    Tondi, Stefano
    De Palma, Rossana
    Marzocchi, Antonio
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (21) : 1948 - 1949